Wednesday saw the Cowboys introduce their new defensive coordinator to the public, and it's safe to say Christian Parker got off to a very strong start. Highlights from his debut press conference ...

The Dolphins have a decision to make about quarterback Tua Tagovailoa. Few expect him to return as the starting quarterback for 2026. Thanks, however, to the ill-advised contract that former G.M.

Miami had signed Hill to $120m extension in 2022 Pass rusher Bradley Chubb also cut in flurry of moves The Miami Dolphins are releasing star wide receiver Tyreek Hill in a cost-cutting move, multiple ...

The frenzy of NFL free agency is most often focused on the players signing in new spots -- but some of the most impactful moves each year are the cuts teams make in the pursuit of coveted cap space.

Texans RB Joe Mixon (left) missed the entire 2025 season and could be a prime cut candidate for Houston. Meanwhile, Kirk Cousins (right) could be a salary-cap casualty, but the Atlanta Falcons might ...

The Miami Dolphins are parting ways with their 2025 sacks leader. Miami was set to enter the offseason $17.4 million over the NFL's salary cap for 2026, according to OverTheCap. Chubb's cap hit for ...

Head coach Mike Vrabel finished his first season with the New England Patriots with a 29-13 loss to the Seattle Seahawks in the Super Bowl. While the Patriots liked the progress they made under Vrabel ...

The small-cap Russell 2000 was once again outperforming its larger rivals on Friday after the latest inflation report helped revive hopes for multiple Fed rate cuts in 2026. The index was up 43 points ...

Fred Warner has his sights on the Lombardi Trophy next season. Chris Graythen / Getty Images It was a hectic Super Bowl week for the San Francisco 49ers, who watched the hated Seattle Seahawks lift ...

The Bears could look seriously at cutting a player or two for salary cap purposes if they can't restructure enough contracts for more cap space, and here are the most likely victims. As the Bears ...

Eli Lilly's GLP-1 drugs have seen strong demand, which has investors excited about the future. The company knows that its GLP-1 success won't last forever and is exploring additional paths. Eli Lilly ...